Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10520560 | Transfusion Clinique et Biologique | 2013 | 10 Pages |
Abstract
Late evolution of peripheral arterial disease consists in the apparition of critical limb ischemia. Surgical treatments allow to treat these patients during long time; however, in most patients, especially the diabetic ones, there a very few options and the clinical evolution is rapidly dramatic. For these reasons, the critical limb ischemia is one of the first diseases treated by genic or cellular therapies aiming to improve blood flow perfusion in the lower-limbs. In this short review, we describe the main clinical trials of genic therapy; most of them have been abandoned because serious side effects, modest effects and major risks. Different types of stem cells are now used for cell therapy: endothelial progenitor cells, early or late, activated or not, mesenchymal stem cells, embryonic stem cells and human induced pluripotent stem cells. Problems of characterization are described and the results of the most important clinical trials are reported.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
D. Smadja, J.-S. Silvestre, B.I. Lévy,